Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-12-08 00:00:00 ET · period of report 2023-12-06 · accession 0001209191-23-057986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-08 | 2023-12-06 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.03 | -8,396 | 29.5K | -22% | -$1.01M |
| D | 2023-12-08 | 2023-12-06 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $77.81 | +8,396 | 37.9K | +28% | +$653.3K |
| D | 2023-12-08 | 2023-12-06 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $77.81 | -8,396 | 51.5K | -14% | -$653.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-06 | S | D | 8,396 | $120.03 | 29,521 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F3) 28,336 of the outstanding shares are held by The Stephen Tayor and Eiry W. Roberts Joint Trust Agreement, of which Dr. Roberts has voting and investment power. |
| 2 | Common | Common Stock | 2023-12-06 | M | A | 8,396 | $77.81 | 37,917 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2023-12-06 | M | D | 8,396 | $77.81 | 51,464 | D | $77.81 · — to 2028-01-08 | 8,396 Common Stock | (F4) Option granted January 8, 2018 and vests at 25% upon first anniversary (January 8, 2019) and remaining 75% vesting in 36 equal monthly installments beginning February 8, 2019. |